Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 262.93 USD 0.35% Market Closed
Market Cap: 18.4B USD
Have any thoughts about
Insulet Corp?
Write Note

Wall Street
Price Targets

PODD Price Targets Summary
Insulet Corp

Wall Street analysts forecast PODD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PODD is 282.11 USD with a low forecast of 236.34 USD and a high forecast of 332.85 USD.

Lowest
Price Target
236.34 USD
10% Downside
Average
Price Target
282.11 USD
7% Upside
Highest
Price Target
332.85 USD
27% Upside

PODD Last Price Targets
Insulet Corp

The latest public price target was made on Nov 8, 2024 by Marie Thibault from BTIG , who expects PODD stock to rise by 3% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Marie Thibault
BTIG
270 USD
Upside 3%
2 weeks ago
Nov 8, 2024
Insulet Corporation (PODD) PT Raised to $270 at BTIG
StreetInsider
Lee Hambright
Bernstein
300 USD
Upside 14%
2 weeks ago
Nov 5, 2024
Bernstein SocGen Group Starts Insulet Corporation (PODD) at Outperform
StreetInsider
Jayson Bedford
Raymond James
260 USD
Downside 1%
1 month ago
Oct 14, 2024
Insulet price target raised to $260 from $213 at Raymond James
TheFly
Matt O'Brien
Piper Sandler
285 USD
Upside 8%
2 months ago
Sep 17, 2024
Insulet price target raised to $285 from $230 at Piper Sandler
TheFly
Matt O'Brien
Piper Sandler
230 USD
Downside 13%
2 months ago
Aug 27, 2024
Piper Sandler Reiterates Overweight Rating on Insulet Corporation (PODD)
StreetInsider
Steven Lichtman
Oppenheimer
233 USD
Downside 11%
2 months ago
Aug 27, 2024
Oppenheimer Reiterates Outperform Rating on Insulet Corporation (PODD)
StreetInsider
Matthew Taylor
Jefferies
260 USD
Downside 1%
2 months ago
Aug 27, 2024
Jefferies Reiterates Buy Rating on Insulet Corporation (PODD)
StreetInsider
Marie Thibault
BTIG
250 USD
Downside 5%
3 months ago
Aug 9, 2024
Insulet price target lowered to $250 from $270 at BTIG
TheFly
Matt Miksic
Barclays
200 USD
Downside 24%
6 months ago
May 13, 2024
Insulet price target lowered to $200 from $213 at Barclays
TheFly
Mike Polark
Wolfe Research
200 USD
Downside 24%
6 months ago
May 7, 2024
Insulet upgraded to Outperform from Peer Perform at Wolfe Research
TheFly
Kyle Rose
Canaccord Genuity
226 USD
Downside 14%
8 months ago
Mar 21, 2024
Canaccord Genuity Likes Insulet Corporation (PODD) Management Appointment
StreetInsider
Show More Price Targets
Show Less Price Targets
Marie Thibault
BTIG
Price Target 270 USD
Upside/Downside 3%
View Source
Lee Hambright
Bernstein
Price Target 300 USD
Upside/Downside 14%
View Source
Jayson Bedford
Raymond James
Price Target 260 USD
Upside/Downside 1%
View Source
Matt O'Brien
Piper Sandler
Price Target 285 USD
Upside/Downside 8%
View Source
Matt O'Brien
Piper Sandler
Price Target 230 USD
Upside/Downside 13%
View Source
Steven Lichtman
Oppenheimer
Price Target 233 USD
Upside/Downside 11%
View Source
Matthew Taylor
Jefferies
Price Target 260 USD
Upside/Downside 1%
View Source
Marie Thibault
BTIG
Price Target 250 USD
Upside/Downside 5%
View Source
Matt Miksic
Barclays
Price Target 200 USD
Upside/Downside 24%
View Source
Mike Polark
Wolfe Research
Price Target 200 USD
Upside/Downside 24%
View Source
Kyle Rose
Canaccord Genuity
Price Target 226 USD
Upside/Downside 14%
View Source
Show More Price Targets
Show Less Price Targets
Insulet Corp Competitors:
Price Targets
ABT
Abbott Laboratories
13% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
44% Upside
EMBLA
Embla Medical hf
9% Upside
2235
MicroTech Medical Hangzhou Co Ltd
4% Upside
NARI
Inari Medical Inc
33% Upside
002901
Double Medical Technology Inc
53% Upside
6960
Fukuda Denshi Co Ltd
15% Downside
SN
Smith & Nephew PLC
28% Upside

Revenue
Forecast

Revenue Estimate
Insulet Corp

For the last 8 years the compound annual growth rate for Insulet Corp's revenue is 26%. The projected CAGR for the next 3 years is 19%.

26%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Insulet Corp

The compound annual growth rate of Insulet Corp's operating income for the next 3 years is 29%.

N/A
Past Growth
29%
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Insulet Corp

The compound annual growth rate of Insulet Corp's net income for the next 3 years is 19%.

N/A
Past Growth
19%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PODD's stock price target?
Price Target
282.11 USD

According to Wall Street analysts, the average 1-year price target for PODD is 282.11 USD with a low forecast of 236.34 USD and a high forecast of 332.85 USD.

What is Insulet Corp's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Insulet Corp's revenue is 26%. The projected CAGR for the next 3 years is 19%.

What is Insulet Corp's Operating Income forecast?
Projected CAGR
29%

The compound annual growth rate of Insulet Corp's operating income for the next 3 years is 29%.

What is Insulet Corp's Net Income forecast?
Projected CAGR
19%

The compound annual growth rate of Insulet Corp's net income for the next 3 years is 19%.

Back to Top